Peter Rahmer - 27 Mar 2024 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Title: Chief Corporate Development Officer
Signature
/s/ Brian Adams, as attorney-in-fact
Issuer symbol
RLAY
Transactions as of
27 Mar 2024
Net transactions value
-$2,295
Form type
4
Filing time
29 Mar 2024, 16:15:14 UTC
Previous filing
31 Jan 2024
Next filing
29 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale $2,295 -298 -0.06% $7.70 514,679 27 Mar 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on March 26, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 470,848 shares underlying RSUs.

Remarks:

Title: Chief Corporate Development Officer